Vaxart Inc. (VXRT)

3 -0.01 (-0.332%)

IEX Real-Time Price

August 17, 2018 EST.

NASDAQ Capital Market : Healthcare

Prev Close 3.01

Price Open 2.96

Volume: 4,954

Avg Volume: 12,380

Market Cap: 21.42M

P/E Ratio -0.56

52 Wk Range 2.76-11.88



VXRT Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-07-31
4.8M
81,984
3.89
1.71%

2018-07-13
4.8M
86,786
1.93
1.81%

2018-06-29
4.8M
89,928
1.07
1.88%

2018-06-15
4.8M
73,147
0.67
1.52%




VXRT Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-05-15
Q3 2018
N/A
0.00 (0)
0.49
0.00

2018-02-08
Q2 2018
N/A
0.00 (0)
-0.99
0.00

2017-11-02
Q1 2018
N/A
-1.54 (1)
-1.54
0.00

2017-08-31
Q4 2017
N/A
-0.17 (1)
-0.15
0.02

News

Vaxart reports Q2 results (2018-08-09 08:11 SeekingAlpha)

Vaxart (NASDAQ: VXRT ): Q2 EPS of -$1.24 More news on: Vaxart, Inc., Earnings news and commentary, Healthcare stocks news, , Read more …

 

Vaxart Announces Second Quarter 2018 Financial Results and Corporate Update (2018-08-09 08:00 Business Wire)

Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced financial results for the second quarter ended June 30, 2018 and provided a corporate update. "We are encouraged by the rece…

 


Statistics

Shares Outstanding: 7.14M

Top 15 Institution Percent: 11.30

Price To Sales: 4.47

Price To Book: 0.96

Revenue: 2.80M

Gross Profit: N/A

Cash: 63.50M

Debt: 600000

Return On Assets: -35.50

Return On Equity: -75.98

Profit Margin: N/A

Price History

Beta: 0.05

50-day Moving Avg: 3.12

200-day Moving Avg: 5.31

YTD Change: -49.21

5-day Change: -0.99

1-month Change: -7.12

3-month Change: -40.94

6-month Change: -51.46

1-year Change: -52.15

Revenue Per Share: 0.00

Revenue Per Employee: 175000.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Vaxart Inc.

Exchange: NASDAQ Capital Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.aviragen.com

Vaxart Inc, formerly known as Aviragen Therapeutics Inc is a bio-pharmaceutical company. It is engaged in developing direct-acting antivirals to treat infections that affect a number of patients.